Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Meher BEN Abdelghani"'
Autor:
Joris Mallard, Elyse Hucteau, Roland Schott, Thierry Petit, Martin Demarchi, Christine Belletier, Meher Ben Abdelghani, Hélène Carinato, Pascale Chiappa, Cathie Fischbach, Michal Kalish-Weindling, Audren Bousinière, Stéphane Dufour, Fabrice Favret, Xavier Pivot, Thomas J. Hureau, Allan F. Pagano
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Cancer cachexia and exacerbated fatigue represent two hallmarks in cancer patients, negatively impacting their exercise tolerance and ultimately their quality of life. However, the characterization of patients' physical status and exercis
Externí odkaz:
https://doaj.org/article/9a0f99a204684336a514fe95853ad6e5
Autor:
Stefano Kim, Marine Jary, Thierry André, Véronique Vendrely, Bruno Buecher, Eric François, François-Clément Bidard, Sarah Dumont, Emmanuelle Samalin, Didier Peiffert, Simon Pernot, Nabil Baba-Hamed, Farid El Hajbi, Olivier Bouché, Jérôme Desrame, Aurélie Parzy, Mustapha Zoubir, Christophe Louvet, Jean-Baptiste Bachet, Thierry Nguyen, Meher Ben Abdelghani, Denis Smith, Christelle De La Fouchardière, Thomas Aparicio, Jaafar Bennouna, Jean-Marc Gornet, Marion Jacquin, Franck Bonnetain, Christophe Borg
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background The squamous cell carcinoma of the anus (SCCA) is a rare disease, but its incidence is markedly increasing. About 15% of patients are diagnosed at metastatic stage, and more than 20% with a localized disease treated by chemoradiot
Externí odkaz:
https://doaj.org/article/de947b484ce94cb3bfad51574aee5bb2
Publikováno v:
Hépato-Gastro & Oncologie Digestive. 30:180-194
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2525e568b82e5de8c89354eedd39cd17
https://doi.org/10.1684/hpg.2023.2529
https://doi.org/10.1684/hpg.2023.2529
Autor:
Thierry, Conroy, Florence, Castan, Anthony, Lopez, Anthony, Turpin, Meher, Ben Abdelghani, Alice C, Wei, Emmanuel, Mitry, James J, Biagi, Ludovic, Evesque, Pascal, Artru, Thierry, Lecomte, Eric, Assenat, Lucile, Bauguion, Marc, Ychou, Olivier, Bouché, Laure, Monard, Aurélien, Lambert, Pascal, Hammel, Chris, O'Callaghan
Publikováno v:
JAMA oncology. 8(11)
ImportanceEarly results at 3 years from the PRODIGE 24/Canadian Cancer Trials Group PA6 randomized clinical trial showed survival benefits with adjuvant treatment with modified FOLFIRINOX vs gemcitabine in patients with resected pancreatic ductal ade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d98f64a986454986ad7045715dc306c2
https://pubmed.ncbi.nlm.nih.gov/36416803
https://pubmed.ncbi.nlm.nih.gov/36416803
Autor:
Caroline Gronnier, Christophe Mariette, Come Lepage, Carole Monterymard, Marine Jary, Aurélie Ferru, Mathieu Baconnier, Xavier Adhoute, David Tavan, Hervé Perrier, Véronique Guerin-Meyer, Cédric Lecaille, Nathalie Bonichon-Lamichhane, Didier Pillon, Oana Cojocarasu, Joëlle Egreteau, Xavier Benoit D’journo, Laétitia Dahan, Christophe Locher, Patrick Texereau, Denis Collet, Pierre Michel, Meher Ben Abdelghani, Rosine Guimbaud, Marie Muller, Olivier Bouché, Guillaume Piessen
Publikováno v:
Cancers; Volume 15; Issue 7; Pages: 2188
Purpose: While perioperative chemotherapy provides a survival benefit over surgery alone in gastric and gastroesophageal junction (G/GEJ) adenocarcinomas, the results need to be improved. This study aimed to evaluate the efficacy and safety of periop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b95d328b576d89ce05bd520e47acdc5
Autor:
Thierry Conroy, Jean-François Bosset, Pierre-Luc Etienne, Emmanuel Rio, Éric François, Nathalie Mesgouez-Nebout, Véronique Vendrely, Xavier Artignan, Olivier Bouché, Dany Gargot, Valérie Boige, Nathalie Bonichon-Lamichhane, Christophe Louvet, Clotilde Morand, Christelle de la Fouchardière, Najib Lamfichekh, Béata Juzyna, Claire Jouffroy-Zeller, Eric Rullier, Frédéric Marchal, Sophie Gourgou, Florence Castan, Christophe Borg, Philippe Ronchin, Jean-François Seitz, Stéphane Corbinais, Emmanuel Maillard, Monique Noirclerc, Farid El Hajbi, Anne-Laure Villing, Yves Bécouarn, Lam Foong Fat Lam Kam Sang, Pascal Artru, Jean-Baptiste Bachet, Fayçal Hocine, Catherine Ligeza-Poisson, Claire Vautravers, Meher Ben Abdelghani, Thomas Aparicio, Elise Desot, Isabelle Marquis
Publikováno v:
The Lancet Oncology. 22:702-715
Summary Background Treatment of locally advanced rectal cancer with chemoradiotherapy, surgery, and adjuvant chemotherapy controls local disease, but distant metastases remain common. We aimed to assess whether administering neoadjuvant chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abbf10530c95450b1ac17465cd9fe2ad
https://doi.org/10.1016/s1470-2045(21)00079-6
https://doi.org/10.1016/s1470-2045(21)00079-6
Autor:
Laetitia Dahan, Romain Cohen, Meher Ben Abdelghani, Hélène Castanié, Christophe Tournigand, Jean-Philippe Metges, Paul Gougis, Anthony Turpin, Cindy Neuzillet, Jean-Frédéric Blanc, Dewi Vernerey, David Tougeron, Benoit Rousseau, Marc Hilmi, Marie-Line Garcia-Larnicol, Alice Boilève
Publikováno v:
European Journal of Cancer. 143:55-63
Background The IMMUNOBIL PRODIGE 57 trial is a non-comparative randomized phase II study assessing the efficacy and safety of the durvalumab (an anti-PD-L1) and tremelimumab (an anti-CTLA4) combination with or without weekly paclitaxel in patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47caa0ac920fa3995d70b0feb4078e9d
https://doi.org/10.1016/j.ejca.2020.10.027
https://doi.org/10.1016/j.ejca.2020.10.027
Autor:
Clélia Coutzac, Frederic Bibeau, Meher Ben Abdelghani, Thomas Aparicio, Romain Cohen, Elodie Coquan, Olivier Dubreuil, Ludovic Evesque, François Ghiringhelli, Stefano Kim, Samuel Lesourd, Cindy Neuzillet, Jean-Marc Phelip, Guillaume Piessen, Philippe Rochigneux, Emmanuelle Samalin, Emilie Soularue, Yann Touchefeu, David Tougeron, Aziz Zaanan, Christelle de la Fouchardière
Publikováno v:
Digestive and Liver Disease
Digestive and Liver Disease, 2022, 54 (10), pp.1335-1341. ⟨10.1016/j.dld.2022.07.008⟩
Digestive and Liver Disease, 2022, 54 (10), pp.1335-1341. ⟨10.1016/j.dld.2022.07.008⟩
International audience; Background: Immune checkpoint inhibitors (ICI) targeting Programmed death-1 (PD-1) have shown their efficacy in advanced MSI/dMMR (microsatellite instability/deficient mismatch repair) tumors. The MSI/dMMR status predicts clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f54d5c46065bce3549e79b161db7c16c
https://hal.science/hal-03837196/file/PIIS1590865822005916.pdf
https://hal.science/hal-03837196/file/PIIS1590865822005916.pdf
Autor:
Emmanuelle Samalin, Hélène Senellart, Ludovic Evesque, Olivier Bouché, Faiza Khemissa, Christelle De La Fouchardiere, Anthony Lopez, Slimane Dermeche, Damien Botsen, David Tougeron, Aziz Zaanan, Meher BEN Abdelghani, Emmanuel Guardiola, Olivier Dubreuil, Valérie Le Brun Ly, Audrey Hennequin, Nicolas De Sousa Carvalho, Florence Castan, Anthony Turpin
Publikováno v:
Journal of Clinical Oncology. 41:387-387
387 Background: Several options have been evaluated as 2nd line treatment in mGA after failure of 1st line platinum based chemotherapy including taxanes and IRI as monotherapies or paclitaxel combined with ramucirumab but with a limited efficacy. REG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3033ac15a3c6557a7cd3c44f4f53e51
https://doi.org/10.1200/jco.2023.41.4_suppl.387
https://doi.org/10.1200/jco.2023.41.4_suppl.387
Autor:
Eric Assenat, Meher BEN Abdelghani, Maeva Monnier, Herve Perrier, Faiza Khemissa, Romain Desgrippes, Marie-Pierre Galais, Yves Rinaldi, Come Lepage, Raphael Tetreau, Pierre Senesse
Publikováno v:
Journal of Clinical Oncology. 41:92-92
92 Background: Adjuvant chemotherapy is the current worldwide standard of care for stage III colorectal cancer (CRC) but it leads to significant neurotoxicity. We have shown in 2 cohorts of CRC patients treated with Oxaliplatin (Ox) that Ox-due neuro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa5ea06e7afb2e7ec749f96ab15e3118
https://doi.org/10.1200/jco.2023.41.4_suppl.92
https://doi.org/10.1200/jco.2023.41.4_suppl.92